Dane Andreeff - 28 Aug 2023 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Dane Andreeff
Issuer symbol
HSDT
Transactions as of
28 Aug 2023
Net transactions value
+$70,550
Form type
4
Filing time
30 Aug 2023, 20:42:39 UTC
Previous filing
16 Feb 2023
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSDT Common Stock Purchase $17,118 +2,688 +44% $6.37* 8,774 28 Aug 2023 See footnote F1, F2
transaction HSDT Common Stock Purchase $3,585 +563 +45% $6.37* 1,820 28 Aug 2023 See footnote F1, F3
transaction HSDT Common Stock Purchase $10,724 +1,684 +25% $6.37* 8,334 28 Aug 2023 See footnote F1, F4
transaction HSDT Common Stock Purchase $911 +143 +45% $6.37* 458 28 Aug 2023 See footnote F1, F5
transaction HSDT Common Stock Purchase $20,222 +2,646 +30% $7.64* 11,420 30 Aug 2023 See footnote F2
transaction HSDT Common Stock Purchase $4,241 +555 +30% $7.64* 2,375 30 Aug 2023 See footnote F3
transaction HSDT Common Stock Purchase $12,671 +1,658 +20% $7.64* 9,992 30 Aug 2023 See footnote F4
transaction HSDT Common Stock Purchase $1,078 +141 +31% $7.64* 599 30 Aug 2023 See footnote F5
holding HSDT Common Stock 30 28 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The share amount has been adjusted to reflect the reverse stock split effective on August 16, 2023 whereby each fifty shares issued and outstanding prior to the split were combined and converted into one share of common stock.
F2 The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3 The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4 The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5 The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.